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Purpose: To investigate whether retinol dehydrogenase 13 (RDH13) can protect the retina from acute light-induced
damage.
Methods:  We  generated  Rdh13  knockout  mice  using  molecular  biologic  methods  and  assessed  the  associated
morphological and functional changes under room-light conditions by hematoxylin-eosin (H&E), transmission electron
microscopy (TEM), and scotopic electroretinography. Then, the light-damage model was established by exposure to
diffuse white light (3,000 lx) for 48 h. Twenty-four h after light exposure, H&E was used for the histological evaluation.
The thickness of the outer-plus-inner-segment and the outer nuclear layer was measured on sections parallel to the vertical
meridian of the eye. An electroretinography test was performed to assess the functional change. Furthermore, the
impairment of mitochondria was detected by TEM. Finally, the expression of cytochrome c (CytC) and other apoptosis-
related proteins was detected by western blot.
Results: We found that there was no obvious difference in phenotype or function between Rdh13 knockout and wild-type
mice. In Rdh13−/− mice subjected to intense light exposure, the photoreceptor outer-plus-inner-segment and outer nuclear
layer were dramatically shorter, and the amplitudes of a- and b-waves under scotopic conditions were significantly
attenuated. Distinctly swollen mitochondria with disrupted cristae were observed in the photoreceptor inner segments of
Rdh13−/− mice. Increased expression levels of CytC, CytC-responsive apoptosis proteinase activating factor-1 (Apaf-1)
and caspases 3, and other mitochondria apoptosis-related genes (nuclear factor-kappa B P65 [P65] and B-cell lymphoma
2-associated X protein [Bax]) were observed in Rdh13−/− mice.
Conclusions: Rdh13 can protect the retina against acute light-induced retinopathy. The mechanism may involve inhibition
of the mitochondrial apoptosis pathway.
Retinoid dehydrogenase/reductase (RDH) is a subfamily
of  the  short-chain  dehydrogenase/reductase  family  that
participates in the metabolism of steroids, prostaglandins, and
retinoids  [1,2]  and  performs  critical  oxidation-reduction
reactions  during  the  retinoid  cycle  (Figure  1).  RDH11–
RDH14 share sequence similarity and RDH11 is strongly
expressed in the retinal pigment epithelia (RPE) [3,4]; the
other three all localize to the photoreceptor inner segment
[5,6]. It has been demonstrated that 11-cis-RDHs (RDH5,
RDH11) can catalyze the oxidation of 11-cis-retinol to 11-cis-
retinal [7]. All-trans-RDHs (RDH8, RDH12, and RDH14)
have very similar properties and can catalyze the reduction of
all-trans-retinal  to  all-trans-retinol  [5,8-10].  Haeseleer
reported  that  RDH13  lacks  RDH  activity  [5].  Recently,
Belyaeva [11] showed that purified RDH13 can recognize all-
trans-retinaldehydes as substrate in vitro, with nicotinamide-
adenine dinucleotide phosphate (NADPH) as the preferred
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cofactor, and can exhibit catalytic activity as a reductase.
Kinetic analysis revealed that RDH13 exhibited substrate and
cofactor specificity similar to that of RDH11, RDH12, and
RDH14,  but  exhibited  greater  catalytic  efficiency  in  the
reduction of all-trans-retinal to all-trans-retinol than in the
oxidation  of  these  compounds  [11].Thus,  RDH13  is
considered to participate in the retinoid cycle, and it may be
involved in the clearance of all-trans-retinal.
This clearance function of RDH13 is very important.
During the visual cycle, the buildup of some photoisomerized
chromophores can be toxic. Such is the case when all-trans-
retinal is produced but cannot be cleared efficiently from the
photoreceptors. This occurs because, in contrast to retinol,
which  has  been  found  to  be  protective  against  oxidative
damage  [12],  all-trans-retinal  is  detrimental.  The  delayed
clearance of all-trans-retinal leads to the accumulation of its
condensation  products,  diretinoid-pyridinium-ethanolamine
(A2E) and all-trans-retinal dimer (RALdi), which are both
associated with progressive retinal degeneration [13-15]. In
this way, RDH13’s clearance of all-trans-retinal is speculated
to protect the retina from all-trans-retinal-mediated retinal
degeneration,  especially  acute  light-induced  retinopathy,
which is mainly related to the delayed clearance of all-trans-
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1021retinal [16]. Mice lacking proteins critical for all-trans-retinal
clearance  from  photoreceptors  can  develop  severe  RPE/
photoreceptor dystrophy [17]. Here, we disrupted the Rdh13
gene in mice to investigate whether there were associated
morphological and functional changes to the retina and to
determine  whether  Rdh13  could  protect  the  retina  from
intense  light  damage  using  biochemical  and
electrophysiological measurements.
METHODS
All  of  the  procedures  involving  animals  adhered  to  the
Association  for  Research  in  Vision  and  Ophthalmology
statement for the use of animals in ophthalmic and vision
research.
Figure 1. The visual cycle in the vertebrate retina. The classical visual
cycle is a chain of biochemical reactions that are catalyzed by retinoid
dehydrogenase/reductase  (RDH)  in  photoreceptors  or  the  retinal
pigment epithelia (RPE) and are responsible for regenerating visual
pigment following light exposure [28]. The visual process is initiated
by the photoisomerization of 11-cis-retinal (11cRAL) to all-trans-
retinal  (atRAL).  First,  11cRAL  diffuses  from  the  RPE  to
photoreceptor-rod outer segments (OS; rod outer segments, ROS;
and cone outer segments, COS) and is coupled to opsin to generate
rhodopsin  (Rh;  reaction  a).  Then,  in  the  photoreceptor  outer
segments, the absorption of light by rhodopsin causes isomerization
of  the  chromophore  from  the  11-cis  form  to  the  all-trans  form
(reaction b). The atRAL is reduced to all-trans-retinol (atROL) in the
reaction  catalyzed  by  an  nicotinamide-adenine  dinucleotide
phosphate  (NADPH)-dependent  all-trans-retinal-specific
dehydrogenase (all-trans-RDH, RDH8, RDH12; reaction c) [8,22].
Next, atROL diffuses to the RPE, where it is esterified to all-trans-
retinyl-ester  (atRE)  in  a  reaction  catalyzed  by  lecithin:  retinol
acyltransferase (LRAT; reaction d). The isomerization of atRE to
11cROL  is  catalyzed  by  RPE-specific  65  kDa  protein  (RPE65;
reaction  e),  which  is  the  key  step  in  the  retinoid  visual  cycle
[29-31]. 11cROL is then oxidized by 11-cis-RDH (RDH5, RDH11)
to  11cRAL  to  complete  the  retinoid  cycle  (reaction  f).  IPM,
interphotoreceptor matrix; IRBP, inter-photoreceptor retinol binding
protein.
Rdh13 knockout mouse generation and maintenance: A
targeting  vector  was  constructed  by  replacing  the  mouse
Rdh13 genomic 1,661 bp fragment, covering exons 2 and 3,
with  the  1,904  bp  phosphoglycerate  kinase-neomycin
resistance cassette (PGK-Neo cassette) for positive selection.
An external herpes simplex virus-1-thymidine kinase cassette
(HSV-TK cassette) was used for negative selection (Figure
2A). The targeting vector contained 2.9 kb of homologous
DNA  upstream  to  the  PGK-Neo  cassette  and  3.2  kb
downstream  as  homologous  recombination  arms.  The
embryonic stem (ES) cells that had undergone homologous
recombination were identified by PCR (Figure 2B) using two
pairs of primers, whose direction and position is depicted in
Figure 2A. The primers used for the 5′-arm recombination
were (P1) 5′-CTT CTG CTT CTT GCC TAG TTC TTC
TCA-3′ and (P2) 5′-AAT TGC ATC GCA TTG TCT GAG
TAG G-3′. The 3′-arm primers were (P3) 5′-CCA GAG GCC
ACT TGT GTA GCG-3′ and (P4) 5′-GAA GCA AAG AAC
CAA CCC CTC TGA-3′. The correctly recombined ES cells
were subsequently microinjected into blastocysts, which were
in turn implanted into pseudopregnant female recipients to
generate  chimeric  mice.  The  F1  mice  with  germ-line
transmission  of  the  Rdh13  knockout  (KO)  allele  were
heterozygous. These heterozygous mice were identified by
PCR using mouse tails and primers depicted in Figure 2A,
(P5) 5′-CAG GAG GCA ACG TCA TTC TG-3′, (P6) 5′-GCT
CAA TGA CAC TCC AGC AA-3′, (P7) 5′-TGG CTG GAC
GTA AAC TCC TC-3′.
The mutant mice were maintained on a mixed 129Sv/
C57BL/6 background during the earlier generations. Then the
mice were backcrossed with wild-type (WT) line 129SV more
than ten generations to ready them for experimentation. Mice
were housed under specific pathogen-free (SPF) conditions at
a constant room temperature of 22–24 °C with a 12 h:12 h
light-dark cycle. The animals were provided with ad libitum
access to food and water.
Total RNA was extracted using TRIzol (Invitrogen Life
Technologies,  Carlsbad,  CA)  reagent  according  to  the
manufacturer’s  instructions.  First-strand  cDNA  was
synthesized  from  1  µg  of  total  RNA  with  random  6-mer
primers at 25 °C for 10 min and 42 °C for 1 h. One microliter
of the reverse transcription was used as the PCR template.
Immunofluorescence and western blot:
Immunofluorescence—Retinal samples were fixed with
4%  paraformaldehyde  in  phosphate-buffered  saline  and
processed  for  paraffin  embedding.  Sections  were
deparaffinized,  rehydrated,  and  then  treated  with  0.3%
hydrogen peroxide in methyl alcohol for 20 min to block
endogenous  peroxidase  activity.  After  antigen  retrieval  in
citrate buffer by autoclave boiling for 15 min, the sections
were  blocked  for  1  h  with  2%  normal  goat  serum  and
incubated with anti-RDH13 serum at 4 °C overnight. The next
day, the secondary rhodamine conjugated antibody (at 1:1,000
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1022dilution) was applied for 2 h at room temperature. Slides were
mounted  and  visualized  under  a  confocal  laser  scanning
microscope (Leica, Heidelberg, Germany).
Western blot—For western blots, retinas were isolated
and homogenized in radioimmunoprecipitation assay (RIPA)
buffer (Beyotime Biotech, Nantong, Jiangsu, China). Protein
concentration was determined with the BCA protein assay
(Beyotime Biotech), and the supernatants were then separated
by 12% sodium dodecyl sulfate PAGE (SDS–PAGE) and
transferred to polyvinylidene fluoride (PVDF) membranes
(Millipore, Watham, MA). The membrane was blocked in
Tris-buffered saline with 0.05% Tween-20 and 5% nonfat
milk and then rinsed and incubated with primary antibody at
4  °C  overnight.  After  incubation  with  a  horseradish-
peroxidase-conjugated anti-rabbit immunoglobulin G (IgG;
Cell Signaling Technology, Danvers, MA) or anti-mouse IgG
(Chemicon, Temecula, CA) for 2 h at room temperature, the
membranes  were  evaluated  using  enhanced
chemiluminescence  according  to  the  manufacturer’s
instructions. The following antibodies were used for western
blotting: 1:4,000 RDH13 anti-serum, rabbit polyclonal anti-
Fas (Santa Cruz Biotech, Santa Cruz, CA), mouse monoclonal
anti-Bax  (Sigma  Chemical,  St.  Louis,  MO),  mouse
monoclonal anti-caspase 3 (Santa Cruz Biotech), recombinant
rabbit monoclonal anti-TNF-α (Molecular Probes, Eugene,
OR), mouse monoclonal anti-P65 (Molecular Probes), mouse
monoclonal  anti-Apaf-1  (Santa  Cruz  Biotech),  mouse
monoclonal anti-cytochrome c (BD PharMingen, San Diego,
CA),  and  mouse  monoclonal  anti-cytochrome  oxidase  IV
(Molecular Probes).
Figure 2. Generation of Rdh13 knockout mice. A: This is the graphic representation of the Rdh13 gene knockout strategy for the deletion of
Rdh13 exons 2 and 3 in embryonic stem cells. Exons are shown in boxes. The targeting vector was designed to delete exon 2 and exon 3. The
targeting vector contained a 2.9 kb 5′ arm and 3.2 kb 3′ arm. PGK-Neo and HSV-TK cassettes were used for positive and negative selections,
respectively. The genomic positive of the PCR primers for genotyping are indicated by arrows. B: Genomic DNA from ES cell clones was
isolated and analyzed by PCR. The successfully targeted embryonic stem cell DNA was amplified into 6.2 kb and 3.5 kb products for the 5′
arm and 3′ arm, respectively. C: The genotype of Rdh13+/+, Rdh13+/−, and Rdh13−/− mice was detected by PCR. D: Rdh13 transcripts in mouse
liver from Rdh13+/+, Rdh13+/−, and Rdh13−/− mice was analyzed by reverse-transcription PCR. E: The expression pattern of RDH13 protein
in Rdh13+/+, Rdh13+/−, and Rdh13−/− mouse liver was revealed by western blot.
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1023Histology and transmission electron microscopy:
H&E—For  histology,  the  eyecups  were  fixed  in  4%
paraformaldehyde for 20 h, incubated in 20% sucrose, and
then embedded in paraffin. Subsequently, fixed eyes were
sectioned  at  a  thickness  of  5  µm  and  then  stained  with
hematoxylin and eosin solution (H&E; Sigma). An Axioplan
2 imaging microscope (Zeiss, Jena, Germany) was used for
histological evaluation of the sections, and color micrographs
were  obtained  at  5×  and  400×  magnification  using  Zeiss
Axiovision software (Zeiss). The thickness of the outer-plus-
inner-segment (from the external limiting membrane to the
pigment epithelium) and the outer nuclear layer was measured
on sections parallel to the vertical meridian of the eye at a
distance  of  1,400  µm  from  the  optic  nerve  by  the  Zeiss
Axiovision  software  and  plotted  with  standard  deviations
(SDs).
Transmission electron microscopy—For transmission
electron microscopy (TEM), the mice eyecup sections were
fixed  in  2.5%  glutaraldehyde  in  1.0  M  piperazine-1,4-
bisethanesulfonic acid (PIPES), pH 7.4, at 4 °C for 4 h and
then washed three times with 0.1 M sodium phosphate, pH 7.3
and post-fixed with 1% osmium tetroxide in 0.1 M sodium
phosphate, pH 7.3, for 3 h at room temperature. The eyecups
were  dehydrated  using  an  ethanol  and  acetone  series  and
embedded with pure epoxy embedding medium. Then, the
eyecups were sectioned at 70 nm with an LKB-5 microtome
(LKB, Stockholm, Sweden) and stained with 3% uranium
acetate  and  lead  citrate  before  viewing  with  a  JEM-1230
transmission electron microscope (JEOL, Tokyo, Japan).
Electroretinography:  Ganzfeld  electroretinography
(ERG) was used to evaluate Rdh13+/+ and Rdh13−/− mice
(Tomey EP-1000 Erlangen, Germany). After overnight dark
adaptation,  the  mice  were  anesthetized  by  intraperitoneal
injection using 1% pentobarbital sodium (70 mg/kg; Sigma
Chemical) under dim red light. The pupils were dilated with
0.5%  Mydrin-P  (Tropicamide/Phenylephrine;  Santen
Pharmaceutical, Japan). A contact-lens electrode was placed
on the center of the cornea with a drop of sodium hyaluronate,
and a reference electrode and ground electrode were placed in
the middle of the lower eyelid and near the tail, respectively.
The light intensity (2.5 cd/m2) was calibrated and computer
controlled, and the preamplifier bandwidth was set at 0.3–300
Hz. The mice were placed in a Ganzfeld chamber, and the
scotopic response to flash stimuli was measured in both eyes
simultaneously.
Light damage: Light damage was induced as described
in  previously  published  work  [18,19]  with  slight
modifications. Before light exposure, the mice were dark-
adapted for 48 h, and the pupils were dilated under dim red
light  with  0.5%  Mydrin-P.  Light  damage  to  Rdh13+/+and
Rdh13−/−  mice  was  induced  by  exposure  to  diffuse  white
fluorescent light (TLD-30W/965 tubes; Philips, Hamburg,
Germany) for 48 h (lights on at 11:00 AM) with an intensity
of 3,000 lx. After being exposed to bright light, the mice were
maintained in dark-adaptation conditions for 24 h. Analyses
of morphology, function, and apoptosis were then performed
(n=18, each group). Rdh13+/+and Rdh13−/− mice without light
exposure were assigned to the control group.
Terminal deoxynucleotidyl transferase dUTP nick-end
labeling:  Paraffin-embedded  retinal  sections  were
deparaffinized, rehydrated, and pretreated with Proteinase K
(Roche, Mannheim, Germany). Terminal deoxynucleotidyl
transferase dUTP nick-end labeling (TUNEL) assays were
performed with an In Situ Cell Death Detection Kit, TMR red
(Roche), according to the manufacturers’ protocols. Slides
were mounted in Vectashield fluorescence mounting medium
(Vector Laboratories, Burlingame, CA) with DAPI (Sigma
Chemical) for nuclear staining and were visualized under a
confocal laser scanning microscope (Leica).
Statistical analysis: The results were plotted as the mean
±SD. Differences were assessed by the two-tailed Student's t-
test using SPSS 16.0 software (SPSS; Chicago, IL); p<0.05
was considered statistically significant.
RESULTS
Disruption of Rdh13: The gene-targeting strategy employed
resulted in the deletion of Rdh13 exons 2 and 3 (Figure 2A).
Genomic DNA from ES cell clones was isolated and analyzed
by  PCR,  and  the  successfully  targeted  ES  cell  DNA  was
amplified to 6.2 kb and 3.5 kb products for the 5′ arm and the
3′ arm, respectively (Figure 2B). Genotypes were determined
by PCR analysis, which showed that the sizes of the WT and
KO allele products were 510 bp and 424 bp, respectively
(Figure 2C). No Rdh13 transcripts were detected in the livers
of  Rdh13  KO  mice  by  reverse-transcription  (RT)-PCR
analysis (Figure 2D). Western-blot analysis of RDH13 levels
in the livers of Rdh13+/+, Rdh13+/−, and Rdh13−/− mice showed
that protein levels were reduced in heterozygous animals and
absent in Rdh13 KO animals (Figure 2E). After the ablation
of Rdh13, we examined the basic phenotype of Rdh13 KO
mice and found no abnormalities in genotype distribution, sex
ratio, bodyweight, or body length compared with their WT
littermates.  Furthermore,  no  significant  impairment  in
reproduction capability was observed.
Characterization and histology of the Rdh13 knockout mice:
For Rdh13 localization in mouse eyes, immunofluorescence
analysis  showed  that  Rdh13  was  expressed  in  the
photoreceptor  inner  segment  layer,  with  no  apparent
expression in the RPE, photoreceptor outer segments, or outer
nuclear layer in WT mice (Figure 3A). Rdh13 expression was
abolished in the retinas of Rdh13 KO mice, as determined by
immunofluorescence (Figure 3A) and western blot (Figure
3B). Light micrographs of retina sections from Rdh13 KO and
WT mice revealed no major differences in retinal histology at
3 and 10 months of age (Figure 3C, at 3 months and 10
months),  with  normal  lamination  and  numbers  of  cells.
Similarly, TEM at 10 months of age revealed no apparent
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1024Figure 3. Localization, retinal histology, and thickness measurements for the Rdh13 knockout mice. A: Immunofluorescence localization of
Rdh13 (green) was shown in 3-month-old Rdh13+/+ and Rdh13−/− retina paraffin sections. B: western blot analysis of RDH13 protein in wild-
type (WT) and homozygous mice revealed that there was no expression of Rdh13 in the retinas of Rdh13 knockout mice. C: Semi-thin sections
of WT and homozygous mice retinas revealed no major differences in retinal histology at 3 and 10 months of age. D: Transmission electron
microscopy (TEM) of the photoreceptor outer and inner segments and the outer nuclear layer in Rdh13+/+ and Rdh13−/− mice at 10 months
of age revealed no apparent abnormalities. E: The outer-plus-inner-segment and outer nuclear layer thickness for Rdh13−/− and WT mice at
the ages of 3 months and 10 months was valued. Values were mean±SD (n=5, each group). There were no statistically significant differences
between the two genotypes at any distance point. ONH, optic nerve head; RPE, retinal pigment epithelia; OS, outer segments; IS, inner
segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell
layer.
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1025Figure 4. Full-field electroretinogram responses and apoptosis detection in Rdh13+/+ and Rdh13−/− mice. A: The scotopic electroretinogram
responses of Rdh13+/+ and Rdh13−/− mice at 10 months of age were recorded. B: The amplitudes of a- and b-waves for either genotype was
plotted as the mean±SD (n=5, each group), *: p>0.05. C: The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining
showed that there was no obvious apoptosis in both Rdh13+/+ and Rdh13−/− mice at 10 months of age. D: Apoptosis genes expression in
Rdh13+/+, Rdh13+/−, and Rdh13−/− mice was detected by western blots. There was no increased expression level of apoptosis genes in all
genotypes, which was in accordance with the result of TUNEL.TNF-α, tumor necrosis factor alpha; Fas, TNF receptor superfamily member
6; Bax, B-cell lymphoma 2-associated X protein; P65, nuclear factor-kappa B P65; RPE, retinal pigment epithelia; OS, outer segments; IS,
inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion
cell layer.
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1026Figure 5. Light damage in Rdh13-/- mice. Light damage was induced in Rdh13+/+ and Rdh13−/− mice by 48 h exposure to diffuse white light
(3,000 lx). Twenty-four h dark-adaption after light exposure, and morphological and functional assays were performed as described in Methods.
A: Hematoxylin-eosin (H&E) staining showed that the outer-plus-inner-segment and outer nuclear layers of the retina from Rdh13−/− mice
that were exposed to light obviously disintegrated. B: The thicknesses of the outer-plus-inner-segment and outer nuclear layers of all genotypes
exposed to the light and the control group was valued. Values were mean±SD (n=5, each group). There were statistically significant differences
in the thickness of the outer-plus-inner-segment and outer nuclear layer between the light exposed Rdh13−/− mice and the other three groups
at any distance point. C: The scotopic electroretinogram response of Rdh13+/+ and Rdh13−/− mice, which were recorded in all groups. D: The
amplitudes of a- and b-waves in all genotypes was plotted as the mean±SD (n=5, each goup); *: p<0.05. E: Mitochondria in photoreceptor
inner segments of Rdh13+/+ and Rdh13−/− mice exposed to the light were detected by transmission electron microscopy. Distinctly swollen
mitochondria with disrupted cristae were observed in Rdh13−/− mice (arrows). F and G: Cytochrome c (CytC) and apoptotic gene expression
in all groups were analyzed by Western Blot, which revealed that levels of CytC, apoptosis proteinase activating factor-1 (Apaf-1), cleaved
caspase 3, nuclear factor-kappa B P65 (p65) and B-cell lymphoma 2-associated X protein (Bax) were clearly increased in the cytoplasm of
Rdh13−/− mice; ONH, optic nerve head; RPE, retinal pigment epithelia; OS, outer segment; IS, inner segment; ONL, outer nuclear layer; OPL,
outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; UV, ultraviolet.
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1027abnormalities in retinal architecture (Figure 3D). There was
no  evidence  of  any  abnormality  in  Bruch’s  membrane,
increased pigmented body and lipofuscin accumulation in
retinal pigment epithelium cells, or photoreceptor debris. The
thickness of the outer-plus-inner-segment and outer nuclear
layer of the retina was similar at 1,400 µm to that of the optic
nerve head for both genotypes at 3 months and 10 months of
age (Figure 3E).
ERG and apoptosis of Rdh13−/− mice: To evaluate whether
visual function was impaired in Rdh13 KO mice, Ganzfield
ERG was performed on 10-month-old Rdh13+/+ and Rdh13 −/
− mice. The typical ERG records are displayed in Figure 4A.
There was no significant difference in the amplitudes of the
a- and b-waves of the scotopic ERG response between dark-
adapted  Rdh13+/+  and  Rdh13−/−  mice  (a-wave  amplitude:
181.75±19.44  versus  171.32±36.95  μv,  p>0.05;  b-wave
amplitude: 864.45±74.18 versus 730.95±151.52 μv, p>0.05;
Figure 4B). Thus, Rdh13 deletion did not have a significant
effect on the rod-mediated light response. TUNEL detection
showed that there was no obvious apoptosis in 10-month-old
Rdh13−/− mice (Figure 4C), as determined by western blot,
which showed no increased expression levels of caspases 3,
P65,  or  other  mitochondria  apoptosis-related  genes  (Fas,
TNF-α and Bax; Figure 4D).
Light damage in Rdh13-/- mice exposed to intense light: When
Rdh13−/− mice were exposed to 3,000 lx of white light for 48
h,  the  outer-plus-inner-segment  and  outer  nuclear  layers
around the central area (500 μm from the optic nerve head),
where the light of strongest intensity penetrates, disintegrated
(Figure 5A). The thickness values of the outer-plus-inner-
segment were reduced compared to those observed in the
Rdh13+/+mice, especially the outer segment (100 μm superior:
6.57±1.02 versus 14.43±1.45 μm, p<0.05; 100 μm inferior:
7.64±1.36 versus 14.79±2.64 μm, p<0.05; 500 μm superior:
14.95±2.41 versus 27.27±1.14 μm, p<0.05; 500 μm inferior:
13.88±1.11  versus  25.70±3.16  μm,  p<0.05)  (Figure  5B).
There was also a distinct difference in the thickness of the
outer nuclear layer between the Rdh13−/− and Rdh13+/+mice
(100 μm superior: 13.07±4.21 versus 26.62±2.84 μm, p<0.05;
100 μm inferior: 15.01±1.39 versus 24.68±1.70 μm, p<0.05;
500 μm superior: 26.84±2.78 versus 50.52±3.63 μm, p<0.05;
500 μm inferior: 23.86±2.47 versus 40.25±3.71 μm, p<0.05;
Figure 5B). These findings were matched to data obtained by
the full-field ERG, which revealed markedly decreased mean
amplitudes of a- and b-waves under scotopic conditions in the
Rdh13−/−  mice  compared  with  the  Rdh13+/+mice  (a-wave
amplitude: 55.08±6.73 versus 89.38±3.86 μv, p<0.05; b-wave
amplitude: 257.73±69.57 versus 389.30±68.25 μv, p<0.05;
Figure  5C,D).  TEM  showed  that  the  mitochondria  in  the
photoreceptor  inner  segments  of  the  Rdh13−/−  mice  were
distinctly swollen and contained disrupted cristae. In contrast,
the morphology of the mitochondria in the Rdh13+/+ mice was
only minimally affected (Figure 5E). Western blot analysis
revealed  that  levels  of  cytochrome  C  (CytC),  apoptosis
proteinase activating factor-1 (Apaf-1), caspase 3, p65, and
Bax were clearly increased in the cytoplasm of Rdh13−/− mice
(Figure 5F,G).
DISCUSSION
During the visual cycle, there is one important catalytic step
involving the enzymatic reduction of all-trans-retinal to all-
trans-retinol, and it is performed in photoreceptors by all-
trans-RDH [20]. This process is not only essential for the
retinoid cycle but can also protect the retina against oxidative
damage caused by the accumulation of all-trans-retinal, which
is  also  of  great  significance  in  the  occurrence  of  retinal
degeneration [17]. Among the all-trans-RDH family members
participating in the reduction of all-trans-retinal, RDH8 and
RDH12 have been shown to be responsible for clearing all-
trans-retinal  from  the  outer  and  inner  segments  of
photoreceptor cells, respectively [21]. Mutations in RDH8
and RDH12, either singly or in combination, can cause severe
retinal dystrophy [17,22,23]. Recent observations suggest that
RDH13 also participates in the retinoid cycle and catalyzes
the reduction of all-trans-retinal to all-trans-retinol [11]. The
role of RDH13 is not clear, and whether Rdh13 is associated
with severe retinal degeneration remains to be clarified. In our
investigation of Rdh13-KO and WT mice maintained under
room-light conditions, no obvious pathological or abnormal
electrophysiological response was observed in Rdh13−/− mice,
which meant that loss of RDH13 failed to lead to progressive
retinal  degeneration.  This  was  probably  because  the
deficiency  of  RDH13  was  compensated  for  by  other
dehydrogenases and reductases, such as RDH8 and RDH12.
Next,  we  studied  whether  Rdh13  plays  a  role  in  the
abnormal  increase  in  levels  of  all-trans-retinal.  The  light-
damage model, which is mainly related to the accumulation
of  all-trans-retinal,  has  been  established.  The  appropriate
morphological and functional assays have been performed.
Retinal visual function and morphology were preserved in
Rdh13+/+ mice but were dramatically disturbed in Rdh13−/−
mice, which may be because the photoreceptor outer-plus-
inner-segment and outer nuclear layers were shorter. Thus,
Rdh13  seemed  to  reinforce  the  anti-acute  light  damage
vulnerability of the retina and inhibit retinal degeneration
caused by intense light exposure.
Further  observation  showed  that,  24  h  after  light
exposure, mitochondria in the photoreceptor inner segment
were distinctly swollen and contained disrupted cristae in the
Rdh13−/− mice (Figure 5E). This impairment clearly preceded
the major burst of photoreceptor apoptosis (Figure 5A). The
western blot analysis revealed that levels of CytC increased
markedly in the cytosol of the Rdh13−/− mice (Figure 5F). The
release of CytC from mitochondria to the cytosol contributes
to changes in the mitochondrial membrane and triggers the
common  apoptotic  pathway,  which  involves  a  cascade  of
caspases  [24-26]  (Figure  5G).  The  rate  of  mitochondrial
apoptosis was consistently lower in the retinas of Rdh13+/+
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1028mice. Thus, it appears likely that Rdh13 levels were sufficient
to inhibit mitochondrial apoptosis and to protect the retina
against mitochondria-associated cell death. RDH13 has been
found to be a mitochondrial protein rather than a microsomal
protein [27], and the submitochondrial localization of RDH13
is on the outer side of the inner mitochondrial membrane
[11]. One may assume that the localization of RDH13 at the
entrance to the mitochondrial matrix may serve as a barrier
protecting the mitochondria against light-induced oxidative
damage, and Rdh13 may interact with certain mitochondrial
membrane  proteins  to  exert  its  protective  effects.  Further
studies are necessary to explore this potential function of
Rdh13 in mitochondria.
In conclusion, the evidence suggests that Rdh13 protects
specifically against light-induced apoptosis in photoreceptors.
The protective properties of Rdh13 are associated with the
inhibition of mitochondria-associated cell death.
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